BMC NeurologyNeurosciencePeer-reviewed journal article
A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS)
Seyed‐Mahdi Khaligh‐RazaviiD, Maryam SadeghiiD, Mahdiyeh Khanbagi, Chris KalafatisiD, Seyed Massood NabaviiD
- Citations
- 39
- FWCI
- 3.45
- Field percentile
- top 7%
Abstract
BackgroundCognitive impairment is common in patients with MS. Accurate and repeatable measures of cognition have the potential to be used as a marker of disease activity. We developed a 5-minute computerized test to measure cognitive dysfunction in patients with MS. The proposed test -named Integrated Cognitive Assessment (ICA)- is self-administered and language-independent.\n\nObjectiveTo determine ICAs validity as a digital biomarker for assessing cognitive performance in MS.\n\nMethods91 MS patients and 83 healthy controls (HC) took part in substudy 1, in which each participant took the ICA test and the Brief International Cognitive Assessment for MS (BICAMS). We assessed ICAs test-retest reliability, its correlation with BICAMS, its sensitivity to discriminate patients with MS from the HC group, and its accuracy in detecting cognitive dysfunction. In substudy 2, we recruited 48 MS patients, and examined the association between the level of serum neurofilament light (NfL) in these patients and their ICA scores.\n\nResultsICA demonstrated excellent test-retest reliability (r=0.94), with no learning bias (i.e. no significant practice effect); and had high level of convergent validity with BICAMS. ICA was sensitive in discriminating the MS patients from the HC group, and demonstrated a high accuracy (AUC = 95%) in discriminating cognitively normal from cognitively impaired participants. Additionally, we found a strong association (r=-0.79) between ICA score and the level of NfL in MS patients.\n\nConclusionsICA can be used as a digital biomarker for assessment and monitoring of cognitive performance in MS patients. In comparison to standard cognitive tools for MS (e.g. BICAMS), ICA is shorter in duration, does not show a learning bias, is independent of language, and takes advantage of artificial intelligence (AI) to identify cognitive status of patients more accurately. Being a digital test, it further has the potential for easier electronic health record or research database integration.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Validity and cultural generalisability of a 5-minute AI-based, computerised cognitive assessment in Mild Cognitive Impairment and Alzheimer's Dementia
Mohammad Hadi Modarres, Chris Kalafatis, … Seyed‐Mahdi Khaligh‐Razavi·Frontiers in PsychiatryPeer-reviewed·Jul 22, 2021
- Integrated Cognitive Assessment: Speed and Accuracy of Visual Processing as a Reliable Proxy to Cognitive Performance
Seyed‐Mahdi Khaligh‐Razavi, Sina Habibi, … Chris Kalafatis·Scientific ReportsPeer-reviewed·Jan 31, 2019
- Predicting cognition using estimated structural and functional connectivity networks and artificial intelligence in multiple sclerosis
Ceren Tozlu, Dylan Ong, … Amy F. Kuceyeski·bioRxiv·Mar 7, 2025
- Precision of the Integrated Cognitive Assessment for the assessment of neurocognitive performance in athletes
Daniel J. Glassbrook, Paul Louis Chazot, Karen Hind·Applied Neuropsychology AdultPeer-reviewed·Feb 15, 2025
- Brain age estimation is a sensitive marker of processing speed in the early course of multiple sclerosis
Einar August Høgestøl, Gro Owren Nygaard, … Hanne Flinstad Harbo·bioRxiv·May 29, 2019
- Fatigue and cognitive performance change in MS: multifactorial with disparate influences
M Hu, Nils Muhlert, … M Winter·bioRxiv·Sep 13, 2018